Position in GH
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$4,767,203
-$6,242,161 QoQ
Shares Held
31,775
-70.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#204
of 594 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Capricorn Fund Managers Ltd holds $27,674,260 across 7 Diagnostics & Research names. GH ranks #3 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
5,710 | $7,294,582 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
31,274 | $7,092,630 | |
| 3 | GH |
Guardant Health, Inc.
This page
|
31,775 | $4,767,203 | |
| 4 | A |
Agilent Technologies, Inc.
|
30,717 | $4,080,139 | |
| 5 | ILMN |
Illumina, Inc.
|
12,000 | $2,109,960 | |
| 6 | SHC |
Sotera Health Co
|
103,830 | $1,842,982 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
5,673 | $486,764 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,767,203 | 31,775 | Shares | Sole | 2026-07-24 | |
| 2025-12-31 | $11,009,364 | 107,787 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,261,776 | 36,200 | Shares | Sole | 2025-10-17 | |
| No filing history on record for this holder in this stock. | ||||||